Total ion chromatograms obtained by LC-ESI-MS analysis (scan mode: m/z 100 to 1200) of the compounds in assays (incubated for 30 min at 31 °C) containing TycA (100 µg), ATP (1 mM, 100 nmol in 0.1 mL), CoA (1 mM), Mg 2+ (3 mM) and D) α-Phe, G) β-Phe or J) (2R,3S)-PheIso (each at 1 mM). Control assays: Panels E), H), and K) lacked ATP, Panels were loaded with aliquots from each fraction that eluted off the nickel-affinity column and stained with Coomassie Blue. Fractions that contained >95% pure protein corresponding to a molecular weight consistent with that of TycA and TycA-S563A at 123 kDa were combined.
The enzymes eluted in ~50 mM imidazole (100 mL) and were separately loaded into a Centriprep size-selective (100,000 MWCO) centrifugal filtration unit (Millipore, Billerica, MA). The protein solutions were concentrated to 1 mL, and the buffer was exchanged with the Assay Buffer (50 mM HEPES containing 100 mM NaCl and 1 mM EDTA at pH 8. 
Synthesis of [N-Boc-(S-(S)-α-and -(R/S)-β-Phenylalanyl)-N-acetyl)]cysteamine.
( and extracted with an equal volume of 10% aqueous NaHCO 3 . The aqueous layer was separated, and the organic layer was extracted twice more with 10% aqueous NaHCO 3 . The organic fraction was dried (Na 2 SO 4 ), filtered, and the solvent was removed under vacuum.
The resultant crude product was purified by silica gel flash chromatography (3 -5% gradient 
Synthesis of [(S-(S)-α-and -(R/S)-β-Phenylalanyl)-N-acetyl)]cysteamine.
3'
To remove the Boc groups, N-Boc-(S)-α-and -(R/S)-β-phenylalanyl-SNAC were separately dissolved in dichloromethane (4 mL), and trifluoroacetic acid was added dropwise over 4 h at 0 °C. The reaction progress was monitored by normal-phase thin layer chromatography (5% methanol in chloroform). Excess trifluoroacetic acid was removed prior to isolating the (S)-α-phenylalanyl-SNAC by concentrating the reaction volume to 2 mL under vacuum, diluting 2-fold in dichloromethane, and then concentrating to 1 -2 mL. This dilution/concentration cycle was repeated three times, after which, the solvent was removed completely. To the residue containing (S)-α-phenylalanyl-SNAC was added ethyl acetate and dilute aqueous NaOH at 0 °C to partition the (S)-α-phenylalanyl-SNAC and aqueous soluble contaminants, respectively. The organic layer was decanted and then removed under vacuum. Water (2 mL) was added to the remaining residue to which 1 M HCl (2 mL) was added at 0 °C. Ethyl acetate was added (2 × 2 mL) to extract any remaining t-butanol and SNAC, and the organic layer was decanted. The water fraction was lyophilized to yield (S)- After deprotection of (N-Boc)-(R/S)-β-phenylalanyl-SNAC, excess trifluoroacetic acid was removed prior to isolating the product, as described above, except the residue was dissolved in 1 M HCl (2 mL, at 0 °C) to exchange the trifluoroacetate salt for the hydrochloride salt of the product. The sample was lyophilized to dryness, resulting in the hydrochloride salt of (R/S)-β-phenylalanyl-SNAC (48 mg, ~88.1% yield). 
Synthesis of (S-[(2R,3S)-Phenylisoserinyl]-N-acetyl)cysteamine.
(2R,3S)-Phenylisoserinyl-SNAC•HCl salt N-Boc-(2S,3R)-Phenylisoserinyl SNAC was synthesized according to the procedure described for the α-and β-phenylalanyl SNAC thioesters, with slight modifications. Briefly,
to N-Boc-(2S,3R)-phenylisoserine (100 mg, 0.36 mmol) dissolved in tetrahydrofuran (~6
